Details for 2020757941

Up to date per 03.04.2026

Actions

Title / Product Name

N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4,5,6,7-TETRAHYDROBENZOFURAN-2-SULFONAMID-DERIVATE UND ÄHNLICHE VERBINDUNGEN ALS NLPR3 MODULATOREN ZUR BEHANDLUNG VON MULTIPLER SKLEROSE (MS)

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020757941

EP Publication Number

3999496

E-Number

1752179

Language

PCT Number

IB20000634

Publication Date

25.05.2022 A

18.12.2024 B1

Registration Date

18.12.2024

AT Publication Date

15.01.2025

Application Date

16.07.2020

Registration Number

Priorities

17.07.2019

201962875402 P

IPC

C07D 307/82 20060101AFI20210122BHEP

Maximum Duration of Protection

16.07.2040

Owner

Zomagen Biosciences Ltd662 Encinitas Blvd., Suite 250 Encinitas, CA 92024US

Representative

No representatives present

Inventor

MOHAN, Raju662 Encinitas Blvd, Suite 250 Encinitas, CA 92024US

NUSS, John662 Encinitas Blvd, Suite 250 Encinitas, CA 92024US

HARRIS, Jason662 Encinitas Blvd, Suite 250 Encinitas, CA 92024US

YUAN, Shendong662 Encinitas Blvd, Suite 250 Encinitas, CA 92024US